You just read:

BeyondSpring Announces First Patient Enrolled in China in a Global Phase 3 Trial of Plinabulin for Non-Small Cell Lung Cancer

News provided by

BeyondSpring Pharmaceuticals

15 Aug, 2016, 08:00 ET